๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans

Leland Gershell

Stock Analyst at Oppenheimer

(3.90)
# 1,889
Out of 5,184 analysts
735
Total ratings
37.8%
Success rate
4.6%
Average return

Stocks Rated by Leland Gershell

Lexeo Therapeutics
Nov 12, 2026
Reiterated: Buy
Price Target: $20
Current: $3.07
Upside: +551.47%
Capricor Therapeutics
Nov 11, 2026
Reiterated: Buy
Price Target: $54
Current: $11.22
Upside: +381.28%
Palisade Bio
Nov 11, 2026
Reiterated: Buy
Price Target: $8
Current: $1.17
Upside: +583.76%
Compugen
Nov 10, 2026
Reiterated: Buy
Price Target: $4
Current: $2.09
Upside: +91.39%
Xeris Biopharma Holdings
Nov 6, 2026
Reiterated: Buy
Price Target: $18 → $21
Current: $16.52
Upside: +27.12%
UroGen Pharma
Nov 5, 2026
Reiterated: Buy
Price Target: $60
Current: $26.10
Upside: +129.89%
BioMarin Pharmaceutical
Nov 3, 2026
Reiterated: Buy
Price Target: $97 → $94
Current: $58.33
Upside: +61.15%
Ligand Pharmaceuticals
Oct 30, 2026
Reiterated: Buy
Price Target: $326 → $346
Current: $316.83
Upside: +9.21%
Aardvark Therapeutics
Oct 26, 2026
Downgraded: Hold
Price Target: n/a
Current: $1.59
Upside: -
Avalo Therapeutics
Oct 26, 2026
Reiterated: Buy
Price Target: $35 → $16
Current: $8.51
Upside: +88.01%
Reiterated: Buy
Price Target: $1,038
Current: $977.58
Upside: +6.18%
Reiterated: Buy
Price Target: $10
Current: $0.9604
Upside: +941.23%
Reiterated: Buy
Price Target: $262 → $312
Current: $259.28
Upside: +20.33%
Reiterated: Buy
Price Target: $230
Current: $46.20
Upside: +397.84%
Rated: Buy
Price Target: $7
Current: $1.42
Upside: +392.96%
Reiterated: Buy
Price Target: $30 → $14
Current: $3.36
Upside: +316.67%
Reiterated: Buy
Price Target: $18
Current: $12.25
Upside: +46.94%
Reiterated: Buy
Price Target: $54
Current: $37.04
Upside: +45.79%
Reiterated: Buy
Price Target: $24 → $25
Current: $14.82
Upside: +68.75%
Rated: Hold
Price Target: n/a
Current: $1.80
Upside: -
Rated: Hold
Price Target: n/a
Current: $3.74
Upside: -
Reiterated: Buy
Price Target: $14
Current: $3.11
Upside: +350.16%
Reiterated: Buy
Price Target: $25 → $28
Current: $2.62
Upside: +968.70%
Reiterated: Buy
Price Target: $10
Current: $1.24
Upside: +706.45%
Rated: Hold
Price Target: n/a
Current: $31.25
Upside: -
Reiterated: Buy
Price Target: $25
Current: $2.14
Upside: +1,068.22%
Rated: Hold
Price Target: n/a
Current: $18.66
Upside: -
Downgraded: Hold
Price Target: n/a
Current: $112.16
Upside: n/a
Initiated Coverage: Buy
Price Target: $80
Current: $21.96
Upside: n/a
Upgraded: Buy
Price Target: $490
Current: $159.85
Upside: n/a
Reiterated: Buy
Price Target: $25
Current: $0.9398
Upside: n/a
Reiterated: Buy
Price Target: $106
Current: $58.53
Upside: n/a
Initiated Coverage: Buy
Price Target: n/a
Current: $1.02
Upside: n/a
Reiterated: Buy
Price Target: n/a
Current: $3.23
Upside: n/a
Reiterated: Buy
Price Target: $11
Current: $0.6622
Upside: n/a
Reiterated: Buy
Price Target: n/a
Current: $1.86
Upside: n/a
Downgraded: Hold
Price Target: n/a
Current: $4.20
Upside: n/a
Reiterated: Buy
Price Target: $60
Current: $0.10
Upside: n/a
Reiterated: Buy
Price Target: $70 → $200
Current: $0.000001
Upside: n/a
Reiterated: Hold
Price Target: n/a
Current: $4.00
Upside: n/a
Initiated Coverage: Buy
Price Target: $8
Current: $0.0078
Upside: n/a
Rated: Buy
Price Target: $12
Current: $0.30531
Upside: n/a
Rated: Buy
Price Target: $7
Current: $1.00
Upside: n/a
Initiated Coverage: Buy
Price Target: $42
Current: $1.35
Upside: n/a
Reiterated: Hold
Price Target: n/a
Current: $0.0004
Upside: n/a
Rated: Hold
Price Target: n/a
Current: $13.19
Upside: n/a
Rated: Hold
Price Target: n/a
Current: $11.71
Upside: n/a
Rated: Hold
Price Target: n/a
Current: $0.481
Upside: n/a
Rated: Hold
Price Target: n/a
Current: $0.0061
Upside: n/a
Reiterated: Buy
Price Target: $7
Current: $0.9851
Upside: n/a
Rated: Hold
Price Target: n/a
Current: $1.05
Upside: n/a
Reiterated: Buy
Price Target: $8
Current: $5.55
Upside: n/a